Consortium of Food Allergy Research
8
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
12.5%
1 terminated/withdrawn out of 8 trials
87.5%
+1.0% vs industry average
0%
0 trials in Phase 3/4
71%
5 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial
Role: collaborator
Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy
Role: collaborator
Impact of Vaccination on Th2 Immunity in Infancy
Role: collaborator
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
Role: collaborator
Oral Immunotherapy for Childhood Egg Allergy
Role: collaborator
Analysis of Response of Subjects With Atopic Dermatitis or Psoriasis to Oral Vitamin D3
Role: collaborator
An Observational Study of Childhood Food Allergy
Role: collaborator
Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
Role: collaborator
All 8 trials loaded